HuGE Literature Finder
Records
1
-
11
| Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer. International journal of cancer 2022 Aug . Gao Guanghui, Cui Longgang, Zhou Fei, Jiang Tao, Wang Wanying, Mao Shiqi, Wu Fengying, Jiang Fangli, Zhang Bei, Bei Ting, Xie Wenchuan, Zhang Cheng, Zhang Hougang, Gao Chan, Zhao Xiaochen, Bai Yuezong, Zhou Caicun, Ren Shengxia |
| FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan. International journal of environmental research and public health 2020 Aug 17 (16): . Li Ju-Pi, Huang Hsien-Cheng, Yang Po-Jen, Chang Chien-Yuan, Chao Yu-Hua, Tsao Thomas Chang-Yao, Huang Hsuan, Hung Yu-Ching, Hsieh Ming-Ju, Yang Shun- |
| Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. Oncotarget 2017 Apr 8 (15): 25300-25309. Xiong Si-Wei, Ma Jianqun, Feng Fen, Fu Wen, Shu Shan-Rong, Ma Tianjiao, Wu Caixia, Liu Guo-Chang, Zhu Jinho |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer. International journal of cancer. Journal international du cancer 2015 Nov 137 (10): 2332-42. Butkiewicz Dorota, Krze?niak Ma?gorzata, Drosik Anna, Giglok Monika, Gdowicz-K?osok Agnieszka, Kosarewicz Agata, Rusin Marek, Mas?yk Barbara, Gawkowska-Suwi?ska Marzena, Suwi?ski Raf |
| FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer. Acta pharmacologica Sinica 2013 Apr 34 (4): 549-54. Fang Hong-mei, Tian Gang, Zhou Li-juan, Zhou Han-ying, Fang Ying-z |
| Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population. Journal of experimental therapeutics & oncology 2013 10 (3): 215-7. Mansoor Qaisar, Fayyaz Sundas, Farooqi Ammad Ahmad, Bhatti Shahzad, Ismail Muhamm |
| FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. International journal of cancer. Journal international du cancer 2009 Jun 124 (12): 2880-5. Falvella Felicia S, Frullanti Elisa, Galvan Antonella, Spinola Monica, Noci Sara, De Cecco Loris, Nosotti Mario, Santambrogio Luigi, Incarbone Matteo, Alloisio Marco, Calabrò Elisa, Pastorino Ugo, Skaug Vidar, Haugen Aage, Taioli Emanuela, Dragani Tommaso |
| Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer. Oncology reports 2008 Nov 20 (5): 1125-30. Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita |
| Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. British journal of cancer 2007 Jun 96 (12): 1904-7. Matakidou A, El Galta R, Rudd M F, Webb E L, Bridle H, Eisen T, Houlston R |
| Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. PloS one 2007 2 (5): e426. Marks Jenifer L, McLellan Michael D, Zakowski Maureen F, Lash Alex E, Kasai Yumi, Broderick Stephen, Sarkaria Inderpal S, Pham Duykhanh, Singh Bhuvanesh, Miner Tracie L, Fewell Ginger A, Fulton Lucinda L, Mardis Elaine R, Wilson Richard K, Kris Mark G, Rusch Valerie W, Varmus Harold, Pao Willi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Nov 30, 2022
- Content source: